By Cailie Burns | Manager of Leadership Giving and Corporate Sponsor
Thanks to donors like you, each and every dollar of the $34 million raised in 2017 is already at work funding innovative studies and clinical trials that are accelerating progress in the fight against rare cancers.
You are helping to empower scientists and doctors to make lifesaving discoveries and advance trailblazing innovations that will help patients everywhere. Raising $34 million this year—and more than $140 million in the eleven years since inception—is all thanks to the determined riders, supporters, patients, researchers, and physicians who are making a lasting impact, like you.
Here are just a few examples of what you are helping to fund:
Precision Prevention
When cancer is identified early, the likelihood of survival increases by 80 percent. Imagine finding someone’s disease long before it fully develops into cancer—and having the power to stop it immediately. Precision prevention is a new field set to change the future of cancer as we know it.
Most current screening methods are insufficient, and many miss the first signs of cancer entirely. Two exceptions are the Pap smear and colonoscopy: both find cancer at its earliest, most treatable stage. Cycle for Survival is seeding a groundbreaking endeavor, run by Luis Diaz, MD, which applies the concepts of precision medicine to healthy individuals in a bold step to ultimately increase survival rates. The team is creating tools to screen and flag those people most likely to develop cancer—triggering a life-saving medical intervention to reduce any chance of disease progression.
The Marie-Josée and Henry R. Kravis Center for Molecular Oncology
The CMO has ushered in a new era of cancer research, diagnosis, and treatment—leading to answers and hope for patients who otherwise had none. Cycle for Survival continues to support this transformative effort. The CMO fuels MSK’s expansive precision oncology venture, identifying cancer-driving genetic mutations and targeting them with superb accuracy.
In this era of personalized medicine, all roads lead back to the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO). Directed by Dr. David Solit, the CMO’s reach stretches far and runs deep. Thanks to Cycle for Survival, CMO researchers are constantly improving MSK-IMPACT, the all-important test used by physicians and scientists to explore and find the genetic mutations that cause cancer. The team recently hit a major milestone: announcing the results of their first 10,000 tumors sequenced. Undoubtedly this work is just getting started, and with Cycle for Survival’s backing, so much more will be achieved.
In just a few short months, participants will again take to the bikes and ride with friends, family, and colleagues to beat rare cancers. Registration for the 2018 events is open and bikes are filling fast! Sign up now and get your team started.
Links:
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
